UK severe asthma patient outcomes in the real-world versus Italy and the USA: REALITI-A at 2 years

被引：0
|
作者：
Weir, J. [1 ]
Egan, B. [1 ]
Heaney, L. [2 ]
Menzies, D. [3 ]
Pfeffer, P. [4 ]
Howarth, P. [5 ]
Chaudhuri, R. [6 ,7 ]
机构：
[1] GSK, UK Med Affairs, Specialty Med, Brentford, England
[2] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast, North Ireland
[3] Glan Clwyd Gen Hosp, Rhyl, Wales
[4] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England
[5] GSK, Global Med Affairs, Specialty Med, Brentford, England
[6] Univ Glasgow, Glasgow, Scotland
[7] Gartnavel Royal Hosp, Glasgow, Scotland
来源：
THORAX | 2023年 / 78卷 / SUPPL_4期
关键词：
D O I：
10.1136/thorax-2023-BTSabstracts.281
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P129
引用
收藏
页码：A184 / A184
页数：1
相关论文
共 50 条
  • [1] Real-world outcomes with mepolizumab in patients with severe asthma and comorbid anxiety/depression: REALITI-A at 2 years
    Chaudhuri, Rekha
    Liu, Mark C.
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert G.
    Demetriou, Lydia
    Howarth, Peter
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [2] The Influence of Administering Mepolizumab by Autoinjector on Real-world Outcomes in Severe Asthma: Results From the REALITI-A Study at 2 Years
    Liu, M. C.
    Pilette, C.
    Bagnasco, D.
    Audicana Berasategui, M. T.
    Smith, A.
    Price, R. G.
    Demetriou, L.
    Hill, D. G.
    Howarth, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [3] Real-world mepolizumab outcomes in severe asthma: REALITI-A post hoc analysis by exacerbation history
    Bagnasco, Diego
    Lougheed, Diane
    Subramanian, Vijay
    Clifton, Ian J.
    Price, Robert G.
    Howarth, Peter
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis
    Harrison, Tim
    Canonica, Giorgio Walter
    Chupp, Geoffrey
    Lee, Jason
    Schleich, Florence
    Welte, Tobias
    Valero, Antonio
    Gemzoe, Kim
    Maxwell, Aoife
    Joksaite, Sandra
    Yang, Shibing
    Howarth, Peter
    Van Dyke, Melissa K.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (04)
  • [5] The impact of mepolizumab self-administration on real-world outcomes in patients with severe asthma: Post hoc analysis of REALITI-A at 2 years
    Canonica, G. W.
    Demetriou, L.
    Schleich, F.
    Pelaia, G.
    Bernstein, D.
    Lee, F. E. H.
    Price, R. G.
    Howarth, P.
    [J]. ALLERGY, 2023, 78 : 185 - 186
  • [6] EFFECTIVENESS AND SAFETY OF MEPOLIZUMAB IN REAL-WORLD CLINICAL PRACTICE: UK PATIENT OUTCOMES FROM THE REALITI-A STUDY
    Kerr, W. A. F.
    Harrison, T. W.
    Loveday, K.
    Joksaite, S.
    Kwon, N.
    [J]. THORAX, 2019, 74 : A140 - A140
  • [7] Real-world outcomes of patients with severe asthma treated with mepolizumab by baseline inhaled corticosteroid dose: Post hoc analysis of realiti-a at 2 years
    Smith, A.
    Patel, M.
    Caruso, C.
    Pilette, C.
    Welte, T.
    Alfonso-Cristancho, R.
    Price, R. G.
    Howarth, P.
    [J]. ALLERGY, 2023, 78 : 50 - 51
  • [8] National Differences in Real-World Outcomes with Mepolizumab Treatment for Patients with Severe Asthma: Results from the REALITI-A Study
    Lee, J. K.
    Schleich, F.
    Canonica, G. W.
    Munoz, X.
    Chaudhuri, R.
    Lee, F. E.
    Howarth, P.
    Price, R. G.
    Yang, S.
    Jakes, R. W.
    Maxwell, A.
    Cristancho, R. Alfonso
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [9] REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma
    Pilette, Charles
    Canonica, Giorgio Walter
    Chaudhuri, Rekha
    Chupp, Geoffrey
    Lee, F. Eun-Hyung
    Lee, Jason Kihyuk
    Almonacid, Carlos
    Welte, Tobias
    Alfonso-Cristancho, Rafael
    Jakes, Rupert W.
    Maxwell, Aoife
    Price, Robert G.
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (10): : 2646 - 2656
  • [10] International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A
    Pilette, Charles
    Canonica, Giorgio Walter
    Chaudhuri, Rekha
    Lee, F. Eun-Hyung
    Lee, Jason Kihyuk
    Sanchez, Carlos Almonacid
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Maxwell, Aoife
    Price, Robert
    Howarth, Peter
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 566 - 566
12345